Skip to main content
https://pbs.twimg.com/media/FDhASfVX0AEdpKX.jpg
Cluster analysis in axSpA pts classified 2 groups (predominantly axial vs peripheral dz) and showed lower TNFi drug survival rates in those with prominent extra-axial manifestations. Abs 0365 #ACR21 #RheumNow @RheumNow https://t.co/ArgQ7mNqeD https://t.co/XqF7rPneMV
Dr. Rachel Tate
06-11-2021
×